Moreover, GD2 is antigenic, which is known to induce anti‐GD2 IgM elevation in melanoma patients (Tai et al., 1985; Takahashi et al., 1999); therefore, GD2+ melanoma cells may be eliminated in patients. Here, CD40LG is linked to melanoma.